PharmaShots | Incisive News in 3 Shots

Subscribe Now

solid biosciences

Solid Biosciences’ SGT-212 Secures the US FDA’s Fast Track Designation for Treating Friedreich’s Ataxia

Solid Biosciences’ SGT-212 Secures the US FDA’s Fast Track Designation for Treating Friedreich’s Ataxia

January 22, 2025

Solid Biosciences Signed an Exclusive License Agreement with Armatus Bio for AAV-SLB101 in Facioscapulohumeral Muscular Dystrophy (FSHD)

Solid Biosciences Signed an Exclusive License Agreement with Armatus Bio for AAV-SLB101 in Facioscapulohumeral Muscular Dystrophy...

March 8, 2024

Solid Biosciences Entered into a Research Collaboration with Phlox Therapeutics to Develop New Therapies for Rare Cardiac Diseases

Solid Biosciences Entered into a Research Collaboration with Phlox Therapeutics to Develop New Therapies for Rare Cardiac Diseases

January 12, 2023

Solid Biosciences to Acquire AavantiBio for Gene Therapy Programs

Solid Biosciences to Acquire AavantiBio for Gene Therapy Programs

October 3, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us